The impact of heparan-sulfate-modified proteoglycans (HSPGs) on Alzheimer’s disease-associated pathways.
Opinion | Be Wary of Flawed Diagnosis Criteria for ME/CFS
Jason is a professor of psychology and a research director. A recent CDC-funded paper in the Journal of Clinical Medicine suggests that the agency’s Fukuda